By contrast, IER5L was consistently upregulated in colorectal (2/2 datasets), lung (1/1 datasets) and prostate (2/4 datasets) tumor specimens when compared to non-cancerous tissue (Fig. 1a), consistent with recent reports [15, 16]. Here, IER5L is linked to neoplasm.